Medical Care
Global Neurodegenerative Disease Treatment Drug Market Research Report 2025
- May 05, 25
- ID: 228161
- Pages: 63
- Figures: 66
- Views: 44
The global market for Neurodegenerative Disease Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neurodegenerative Disease Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurodegenerative Disease Treatment Drug.
The Neurodegenerative Disease Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurodegenerative Disease Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurodegenerative Disease Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie Inc.
Amneal Pharmaceuticals Inc.
Boehringer Ingelheim International Gmbh
Hoffmann-La Roche
Merck & Co. Inc.
Segment by Type
N-methyl-D-aspartate Receptor antagonists
Cholinesterase Inhibitors
Dopamine Agonists
Immunomodulatory Drugs
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurodegenerative Disease Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neurodegenerative Disease Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurodegenerative Disease Treatment Drug.
The Neurodegenerative Disease Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurodegenerative Disease Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurodegenerative Disease Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie Inc.
Amneal Pharmaceuticals Inc.
Boehringer Ingelheim International Gmbh
Hoffmann-La Roche
Merck & Co. Inc.
Segment by Type
N-methyl-D-aspartate Receptor antagonists
Cholinesterase Inhibitors
Dopamine Agonists
Immunomodulatory Drugs
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurodegenerative Disease Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 N-methyl-D-aspartate Receptor antagonists
1.2.3 Cholinesterase Inhibitors
1.2.4 Dopamine Agonists
1.2.5 Immunomodulatory Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurodegenerative Disease Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurodegenerative Disease Treatment Drug Market Perspective (2020-2031)
2.2 Global Neurodegenerative Disease Treatment Drug Growth Trends by Region
2.2.1 Global Neurodegenerative Disease Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neurodegenerative Disease Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Neurodegenerative Disease Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Neurodegenerative Disease Treatment Drug Market Dynamics
2.3.1 Neurodegenerative Disease Treatment Drug Industry Trends
2.3.2 Neurodegenerative Disease Treatment Drug Market Drivers
2.3.3 Neurodegenerative Disease Treatment Drug Market Challenges
2.3.4 Neurodegenerative Disease Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurodegenerative Disease Treatment Drug Players by Revenue
3.1.1 Global Top Neurodegenerative Disease Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Neurodegenerative Disease Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neurodegenerative Disease Treatment Drug Revenue
3.4 Global Neurodegenerative Disease Treatment Drug Market Concentration Ratio
3.4.1 Global Neurodegenerative Disease Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Treatment Drug Revenue in 2024
3.5 Global Key Players of Neurodegenerative Disease Treatment Drug Head office and Area Served
3.6 Global Key Players of Neurodegenerative Disease Treatment Drug, Product and Application
3.7 Global Key Players of Neurodegenerative Disease Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurodegenerative Disease Treatment Drug Breakdown Data by Type
4.1 Global Neurodegenerative Disease Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Neurodegenerative Disease Treatment Drug Breakdown Data by Application
5.1 Global Neurodegenerative Disease Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
6.2 North America Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)
6.4 North America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
7.2 Europe Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
9.2 Latin America Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie Inc.
11.1.1 Abbvie Inc. Company Details
11.1.2 Abbvie Inc. Business Overview
11.1.3 Abbvie Inc. Neurodegenerative Disease Treatment Drug Introduction
11.1.4 Abbvie Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.1.5 Abbvie Inc. Recent Development
11.2 Amneal Pharmaceuticals Inc.
11.2.1 Amneal Pharmaceuticals Inc. Company Details
11.2.2 Amneal Pharmaceuticals Inc. Business Overview
11.2.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Introduction
11.2.4 Amneal Pharmaceuticals Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.2.5 Amneal Pharmaceuticals Inc. Recent Development
11.3 Boehringer Ingelheim International Gmbh
11.3.1 Boehringer Ingelheim International Gmbh Company Details
11.3.2 Boehringer Ingelheim International Gmbh Business Overview
11.3.3 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Introduction
11.3.4 Boehringer Ingelheim International Gmbh Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.3.5 Boehringer Ingelheim International Gmbh Recent Development
11.4 Hoffmann-La Roche
11.4.1 Hoffmann-La Roche Company Details
11.4.2 Hoffmann-La Roche Business Overview
11.4.3 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Introduction
11.4.4 Hoffmann-La Roche Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.4.5 Hoffmann-La Roche Recent Development
11.5 Merck & Co. Inc.
11.5.1 Merck & Co. Inc. Company Details
11.5.2 Merck & Co. Inc. Business Overview
11.5.3 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Introduction
11.5.4 Merck & Co. Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.5.5 Merck & Co. Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 N-methyl-D-aspartate Receptor antagonists
1.2.3 Cholinesterase Inhibitors
1.2.4 Dopamine Agonists
1.2.5 Immunomodulatory Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurodegenerative Disease Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurodegenerative Disease Treatment Drug Market Perspective (2020-2031)
2.2 Global Neurodegenerative Disease Treatment Drug Growth Trends by Region
2.2.1 Global Neurodegenerative Disease Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neurodegenerative Disease Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Neurodegenerative Disease Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Neurodegenerative Disease Treatment Drug Market Dynamics
2.3.1 Neurodegenerative Disease Treatment Drug Industry Trends
2.3.2 Neurodegenerative Disease Treatment Drug Market Drivers
2.3.3 Neurodegenerative Disease Treatment Drug Market Challenges
2.3.4 Neurodegenerative Disease Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurodegenerative Disease Treatment Drug Players by Revenue
3.1.1 Global Top Neurodegenerative Disease Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Neurodegenerative Disease Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neurodegenerative Disease Treatment Drug Revenue
3.4 Global Neurodegenerative Disease Treatment Drug Market Concentration Ratio
3.4.1 Global Neurodegenerative Disease Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Treatment Drug Revenue in 2024
3.5 Global Key Players of Neurodegenerative Disease Treatment Drug Head office and Area Served
3.6 Global Key Players of Neurodegenerative Disease Treatment Drug, Product and Application
3.7 Global Key Players of Neurodegenerative Disease Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurodegenerative Disease Treatment Drug Breakdown Data by Type
4.1 Global Neurodegenerative Disease Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Neurodegenerative Disease Treatment Drug Breakdown Data by Application
5.1 Global Neurodegenerative Disease Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
6.2 North America Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)
6.4 North America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
7.2 Europe Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
9.2 Latin America Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie Inc.
11.1.1 Abbvie Inc. Company Details
11.1.2 Abbvie Inc. Business Overview
11.1.3 Abbvie Inc. Neurodegenerative Disease Treatment Drug Introduction
11.1.4 Abbvie Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.1.5 Abbvie Inc. Recent Development
11.2 Amneal Pharmaceuticals Inc.
11.2.1 Amneal Pharmaceuticals Inc. Company Details
11.2.2 Amneal Pharmaceuticals Inc. Business Overview
11.2.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Introduction
11.2.4 Amneal Pharmaceuticals Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.2.5 Amneal Pharmaceuticals Inc. Recent Development
11.3 Boehringer Ingelheim International Gmbh
11.3.1 Boehringer Ingelheim International Gmbh Company Details
11.3.2 Boehringer Ingelheim International Gmbh Business Overview
11.3.3 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Introduction
11.3.4 Boehringer Ingelheim International Gmbh Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.3.5 Boehringer Ingelheim International Gmbh Recent Development
11.4 Hoffmann-La Roche
11.4.1 Hoffmann-La Roche Company Details
11.4.2 Hoffmann-La Roche Business Overview
11.4.3 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Introduction
11.4.4 Hoffmann-La Roche Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.4.5 Hoffmann-La Roche Recent Development
11.5 Merck & Co. Inc.
11.5.1 Merck & Co. Inc. Company Details
11.5.2 Merck & Co. Inc. Business Overview
11.5.3 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Introduction
11.5.4 Merck & Co. Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025)
11.5.5 Merck & Co. Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of N-methyl-D-aspartate Receptor antagonists
Table 3. Key Players of Cholinesterase Inhibitors
Table 4. Key Players of Dopamine Agonists
Table 5. Key Players of Immunomodulatory Drugs
Table 6. Key Players of Others
Table 7. Global Neurodegenerative Disease Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Neurodegenerative Disease Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Neurodegenerative Disease Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Neurodegenerative Disease Treatment Drug Market Share by Region (2020-2025)
Table 11. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Neurodegenerative Disease Treatment Drug Market Share by Region (2026-2031)
Table 13. Neurodegenerative Disease Treatment Drug Market Trends
Table 14. Neurodegenerative Disease Treatment Drug Market Drivers
Table 15. Neurodegenerative Disease Treatment Drug Market Challenges
Table 16. Neurodegenerative Disease Treatment Drug Market Restraints
Table 17. Global Neurodegenerative Disease Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Neurodegenerative Disease Treatment Drug Market Share by Players (2020-2025)
Table 19. Global Top Neurodegenerative Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment Drug as of 2024)
Table 20. Ranking of Global Top Neurodegenerative Disease Treatment Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Neurodegenerative Disease Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Neurodegenerative Disease Treatment Drug, Headquarters and Area Served
Table 23. Global Key Players of Neurodegenerative Disease Treatment Drug, Product and Application
Table 24. Global Key Players of Neurodegenerative Disease Treatment Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neurodegenerative Disease Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Type (2020-2025)
Table 28. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Type (2026-2031)
Table 30. Global Neurodegenerative Disease Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Application (2020-2025)
Table 32. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Application (2026-2031)
Table 34. North America Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abbvie Inc. Company Details
Table 50. Abbvie Inc. Business Overview
Table 51. Abbvie Inc. Neurodegenerative Disease Treatment Drug Product
Table 52. Abbvie Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 53. Abbvie Inc. Recent Development
Table 54. Amneal Pharmaceuticals Inc. Company Details
Table 55. Amneal Pharmaceuticals Inc. Business Overview
Table 56. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product
Table 57. Amneal Pharmaceuticals Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 58. Amneal Pharmaceuticals Inc. Recent Development
Table 59. Boehringer Ingelheim International Gmbh Company Details
Table 60. Boehringer Ingelheim International Gmbh Business Overview
Table 61. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product
Table 62. Boehringer Ingelheim International Gmbh Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 63. Boehringer Ingelheim International Gmbh Recent Development
Table 64. Hoffmann-La Roche Company Details
Table 65. Hoffmann-La Roche Business Overview
Table 66. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product
Table 67. Hoffmann-La Roche Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 68. Hoffmann-La Roche Recent Development
Table 69. Merck & Co. Inc. Company Details
Table 70. Merck & Co. Inc. Business Overview
Table 71. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product
Table 72. Merck & Co. Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 73. Merck & Co. Inc. Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
Table 77. Authors List of This Report
List of Figures
Figure 1. Neurodegenerative Disease Treatment Drug Picture
Figure 2. Global Neurodegenerative Disease Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neurodegenerative Disease Treatment Drug Market Share by Type: 2024 VS 2031
Figure 4. N-methyl-D-aspartate Receptor antagonists Features
Figure 5. Cholinesterase Inhibitors Features
Figure 6. Dopamine Agonists Features
Figure 7. Immunomodulatory Drugs Features
Figure 8. Others Features
Figure 9. Global Neurodegenerative Disease Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Neurodegenerative Disease Treatment Drug Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Neurodegenerative Disease Treatment Drug Report Years Considered
Figure 15. Global Neurodegenerative Disease Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Neurodegenerative Disease Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Neurodegenerative Disease Treatment Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Neurodegenerative Disease Treatment Drug Market Share by Players in 2024
Figure 19. Global Top Neurodegenerative Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Neurodegenerative Disease Treatment Drug Revenue in 2024
Figure 21. North America Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)
Figure 23. United States Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)
Figure 27. Germany Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Share by Region (2020-2031)
Figure 35. China Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)
Figure 43. Mexico Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)
Figure 47. Turkey Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abbvie Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 51. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 52. Boehringer Ingelheim International Gmbh Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 53. Hoffmann-La Roche Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 54. Merck & Co. Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of N-methyl-D-aspartate Receptor antagonists
Table 3. Key Players of Cholinesterase Inhibitors
Table 4. Key Players of Dopamine Agonists
Table 5. Key Players of Immunomodulatory Drugs
Table 6. Key Players of Others
Table 7. Global Neurodegenerative Disease Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Neurodegenerative Disease Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Neurodegenerative Disease Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Neurodegenerative Disease Treatment Drug Market Share by Region (2020-2025)
Table 11. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Neurodegenerative Disease Treatment Drug Market Share by Region (2026-2031)
Table 13. Neurodegenerative Disease Treatment Drug Market Trends
Table 14. Neurodegenerative Disease Treatment Drug Market Drivers
Table 15. Neurodegenerative Disease Treatment Drug Market Challenges
Table 16. Neurodegenerative Disease Treatment Drug Market Restraints
Table 17. Global Neurodegenerative Disease Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Neurodegenerative Disease Treatment Drug Market Share by Players (2020-2025)
Table 19. Global Top Neurodegenerative Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment Drug as of 2024)
Table 20. Ranking of Global Top Neurodegenerative Disease Treatment Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Neurodegenerative Disease Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Neurodegenerative Disease Treatment Drug, Headquarters and Area Served
Table 23. Global Key Players of Neurodegenerative Disease Treatment Drug, Product and Application
Table 24. Global Key Players of Neurodegenerative Disease Treatment Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neurodegenerative Disease Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Type (2020-2025)
Table 28. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Type (2026-2031)
Table 30. Global Neurodegenerative Disease Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Application (2020-2025)
Table 32. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Application (2026-2031)
Table 34. North America Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abbvie Inc. Company Details
Table 50. Abbvie Inc. Business Overview
Table 51. Abbvie Inc. Neurodegenerative Disease Treatment Drug Product
Table 52. Abbvie Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 53. Abbvie Inc. Recent Development
Table 54. Amneal Pharmaceuticals Inc. Company Details
Table 55. Amneal Pharmaceuticals Inc. Business Overview
Table 56. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product
Table 57. Amneal Pharmaceuticals Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 58. Amneal Pharmaceuticals Inc. Recent Development
Table 59. Boehringer Ingelheim International Gmbh Company Details
Table 60. Boehringer Ingelheim International Gmbh Business Overview
Table 61. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product
Table 62. Boehringer Ingelheim International Gmbh Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 63. Boehringer Ingelheim International Gmbh Recent Development
Table 64. Hoffmann-La Roche Company Details
Table 65. Hoffmann-La Roche Business Overview
Table 66. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product
Table 67. Hoffmann-La Roche Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 68. Hoffmann-La Roche Recent Development
Table 69. Merck & Co. Inc. Company Details
Table 70. Merck & Co. Inc. Business Overview
Table 71. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product
Table 72. Merck & Co. Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2020-2025) & (US$ Million)
Table 73. Merck & Co. Inc. Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
Table 77. Authors List of This Report
List of Figures
Figure 1. Neurodegenerative Disease Treatment Drug Picture
Figure 2. Global Neurodegenerative Disease Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neurodegenerative Disease Treatment Drug Market Share by Type: 2024 VS 2031
Figure 4. N-methyl-D-aspartate Receptor antagonists Features
Figure 5. Cholinesterase Inhibitors Features
Figure 6. Dopamine Agonists Features
Figure 7. Immunomodulatory Drugs Features
Figure 8. Others Features
Figure 9. Global Neurodegenerative Disease Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Neurodegenerative Disease Treatment Drug Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Neurodegenerative Disease Treatment Drug Report Years Considered
Figure 15. Global Neurodegenerative Disease Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Neurodegenerative Disease Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Neurodegenerative Disease Treatment Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Neurodegenerative Disease Treatment Drug Market Share by Players in 2024
Figure 19. Global Top Neurodegenerative Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Neurodegenerative Disease Treatment Drug Revenue in 2024
Figure 21. North America Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)
Figure 23. United States Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)
Figure 27. Germany Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Share by Region (2020-2031)
Figure 35. China Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)
Figure 43. Mexico Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Share by Country (2020-2031)
Figure 47. Turkey Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abbvie Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 51. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 52. Boehringer Ingelheim International Gmbh Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 53. Hoffmann-La Roche Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 54. Merck & Co. Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232